For example, a study in patients with unresectable HCC and advanced biliary tract cancers who progressed after first-line chemotherapy showed an association between the gut microbiome and responses to anti-PD-1 therapy, with enrichment in taxa associated with energy metabolism in responder patients [59]. Here, PDCD1 is linked to hepatocellular carcinoma.